Sempulse® to Exhibit the Halo™ Vital Signs Monitoring System and its BATDOK® Connectivity at SOMA Scientific Assembly 2025
San Marcos, TX – April 30, 2025 – Sempulse, the company Saving Lives by delivering cutting-edge wearable medical technology to those who need it most, is proud to announce its participation in the Special Operations Medical Association (SOMA) 2025 Scientific Assembly. The event will be held May 5-9 in Raleigh, NC at the Raleigh Convention Center.
SOMA 2025 is the premier gathering of the global Special Operations medical community, bringing together military, federal, and civilian healthcare professionals for education, innovation, and collaboration. The annual conference serves as a key venue for showcasing the latest advancements in battlefield medicine and tactical care, with a focus on equipping austere medics and providers with tools that improve survivability and operational readiness.
Sempulse will be exhibiting at Booth #629, where attendees can experience live demonstrations of the FDA-cleared Halo™ Vital Signs Monitoring System and its integration with BATDOK®. This innovative, non-invasive device adheres discreetly behind the ear and continuously captures the five major vital signs—SpO₂, pulse rate, respiratory rate, core body temperature, and skin temperature. During the conference, visitors can observe their vital signs in real-time, even while in motion, highlighting the device’s capability to provide accurate data in dynamic environments.
Sempulse will be showcasing the Sempulse Halo, the world’s only FDA-cleared, non-invasive vital signs monitor purpose-built for the tactical edge. The Halo enables medics to instantly collect and transmit key physiological data on dozens or hundreds of patients — without bulky equipment, complex training, or reduced operations.
Now pre-integrated with both BATDOK® and ATAK, the Sempulse Halo brings vital signs data to Role 1, empowering medics on the battlefield to easily incorporate vital signs into triage, documentation, and decision-making processes — while keeping their focus where it matters most.
“Our mission has always been to save lives at the point of injury,” said Kurt Stump, CEO of Sempulse. “In October 2024, we had our first confirmed life saved using the Sempulse Halo in a live operational setting. It’s proof that our technology in the hands of the right people can make all the difference.”
Visit Sempulse at Booth #629 at SOMA 2025 to experience the Halo firsthand and learn how it is reshaping battlefield and operational medicine. For more information about the Sempulse Halo Platform and the company’s mission to save lives, visit sempulse.com.
About Sempulse:
Founded in 2016, Sempulse is a medical device manufacturer with offices in San Marcos, TX. They are a leading innovator in wearable medical technology. They have developed and patented the first true FDA-cleared medical wearable: a novel, non-invasive vital signs sensor that adheres to the neck and the back of the ear and acquires multiple patients’ vital signs while at rest or on the go, including SpO2, pulse rate, respiratory rate, core body temperature, and skin temperature, plus geolocation and a wealth of environmental information. Sempulse empowers first responders, clinicians, and industry with real-time physiological data inside or out of the hospital, improving patient outcomes when every second counts.
Sempulse’s Halo Platform recently saved its first life. The Sempulse Halo, including the Halo sensor device, the LiveCharts app, and the Command Cloud application, provided real-time physiological data that led to life-saving action in Gwinnett County, GA.
###
If you would like more information about this topic or to speak with the CEO, please email pr@sempulse.com.